Yunyu Chen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Single Molecule

Molecular Dynamics Simulations

Respiratory Syndrome Coronavirus

Top Venues

Antimicrobial agents and chemotherapy

Journal of medical virology

Assay and drug development technologies

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jiahao Zhou, Rui Zhang, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Evaluation of natural products from virtual screenings as SARS-CoV-2 main protease inhibitors using combinational experiments. Natural product research (2024)
Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial agents and chemotherapy (2024)
Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Rui Zhang, Haohao Yan, Jiahao Zhou, Gangan Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors. Journal of medical virology 96 (3) (2024)
Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Rui Zhang, Haohao Yan, Gangan Yan, Xiaoping Liu, Yunyu Chen
Letter to the Editor: Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization Assay. Assay and drug development technologies (2023)
Haohao Yan, Rui Zhang, Gangan Yan, Xiaoping Liu, Ni Li, Yunyu Chen
Validation of baicalein and oridonin as nonspecific SARS-CoV-2 main protease inhibitors. Phytotherapy research : PTR (2023)
Haohao Yan, Rui Zhang, Xiaoping Liu, Yanchang Wang, Yunyu Chen
Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease. Proceedings of the National Academy of Sciences of the United States of America 120 (37) (2023)
Haohao Yan, Rui Zhang, Gangan Yan, Zhicheng Liu, Xiaoli Liu, Xiaoping Liu, Yunyu Chen
Production of a versatile SARS-CoV-2 main protease biosensor based on a dimerization-dependent red fluorescent protein. Journal of medical virology (2022)
Gangan Yan, Dongsheng Li, Yuan Lin, Zhenghao Fu, Haiyan Qi, Xiaoping Liu, Jing Zhang, Shuyi Si, Yunyu Chen
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors. Cell & bioscience 11 (1) (2021)